Asbestos and Lung Cancer

If you or a loved one has been diagnosed with lung cancer after working around asbestos, you may have a valid claim — and you may not be aware of the full range of compensation available to your family. If a smoking history is the reason you assumed otherwise, that's worth a conversation before you decide anything.

Asbestos-related lung cancer is a malignancy of the lung tissue — the bronchi and the lung parenchyma. Mesothelioma is a malignancy of the mesothelial membrane that lines the lung and chest wall. Different tissue, different disease, different behavior, and legally a different kind of case.

However, clinically, asbestos-related lung cancer is not distinguishable from lung cancer with any other cause. Its presentation is identical to any other lung cancer — cough, breathlessness, chest pain, hemoptysis, weight loss, recurrent chest infections — as are its diagnosis and its treatment. There is no pathological finding that identifies a given lung cancer as the asbestos-caused one.

That single fact drives everything else about these claims. With mesothelioma, the diagnosis itself points strongly toward asbestos, because the NCI reports a history of asbestos exposure in about 70% to 80% of mesothelioma cases. With lung cancer there is no equivalent signal, because the disease is common and has other well-established causes. The connection to asbestos has to be built from the exposure history. The pathology will not show it.

Keep in mind that latency applies here as it does across asbestos disease. The CDC describes the interval between first exposure and clinical disease as usually 20 to 40 years, so a cancer appearing decades after the work is entirely consistent with an asbestos cause.

Most people with a viable claim never make one, and the reason is almost always the same.

For instance, many of the workers with the heaviest asbestos exposure — shipyard trades, insulators, boilermakers, refinery and mill workers — also smoked, in eras and workplaces where smoking was close to universal. When lung cancer follows, the natural assumption is that smoking explains it and there is nothing to pursue.

The evidence does not support that assumption. Asbestos and tobacco smoke interact, and the risk in people exposed to both is greater than either exposure produces alone. A 2015 systematic review and meta-analysis reported an additive interaction index of synergy of 1.44, while other analyses have argued the data fit a multiplicative model better. That disagreement is real and unresolved. It is also, for this purpose, beside the point: on either model the two exposures together produce more risk than smoking alone, which is what matters legally.

The legal consequence follows directly. If asbestos and smoking together produced a risk greater than either alone, then asbestos contributed to causing the disease. It is not displaced by the smoking history. In tort terms, a defendant is generally not excused because another cause also contributed.

That said, comparative fault rules in the relevant state may reduce a recovery to reflect the smoking history, and that is a real factor. But reduction is not the same as elimination, and the choice between a reduced claim and no claim is not a close one.

If you've assumed your smoking history ends the matter, that assumption is worth testing.

In a mesothelioma case, the fight is usually about which defendant's product caused it. In a lung cancer case, the fight is frequently about whether asbestos caused it at all.

As a result, the exposure history carries more weight here, and it needs to be stronger. The factors that matter include:

Intensity. How concentrated the exposure was. Direct handling of asbestos products — stripping lagging, cutting pipe covering, mixing insulating cement — supports causation more readily than intermittent bystander exposure.

Duration. How long it continued. Years of daily exposure carries more weight than a brief period.

Latency. Whether the interval between first exposure and diagnosis is consistent with an asbestos cause. A cancer appearing five years after first exposure is not; one appearing thirty-five years after is.

Fiber type and product. The specific products worked with and their asbestos content.

Corroboration. Co-worker testimony, employment and union records, and product identification establishing that the exposure was what the person says it was.

This is why lung cancer claims are usually strongest for the heaviest-exposure trades — the same populations described in pipefitters and boilermakers and shipyard exposure — and why a thin exposure history that would still support a mesothelioma claim may not support a lung cancer claim.

Certain findings independently establish that a person absorbed a substantial dose of asbestos, and they matter considerably in these cases.

Asbestosis. A diagnosis of asbestosis is strong evidence of heavy, prolonged exposure, because the disease is dose-related and generally requires exactly that. Where a person has both asbestosis and lung cancer, the causal argument is materially stronger. See asbestosis.

Pleural plaques or diffuse pleural thickening. These are non-malignant markers of asbestos exposure visible on imaging, and they demonstrate that fibers reached the pleura.

Fiber burden analysis. In some cases, examination of lung tissue can identify and quantify asbestos fibers and asbestos bodies, providing direct physical evidence of retained dose. This requires tissue, and its availability depends on what was taken at biopsy or surgery.

A well-documented occupational history in a recognized high-exposure trade, corroborated by records and co-workers.

Note that some compensation systems and trust criteria formalize these considerations, requiring particular combinations of exposure duration, latency, and imaging or pathology findings before a lung cancer claim qualifies. Criteria differ between trusts and between systems.

These claims draw on three separate bodies of evidence, and the third one is the one people are most tempted to shade.

Medical. The pathology report confirming the lung cancer and its type. Imaging and reports, including any showing plaques, pleural thickening, or interstitial change. Pulmonary function testing. Treating records. Any prior imaging that documents asbestos-related findings predating the cancer — often valuable, and often already in the file from an unrelated investigation years earlier.

Occupational. The full work history — employers, jobsites, trades, dates — reconstructed from Social Security earnings records, union records, military service records, and employer records. Product identification connecting the person to specific manufacturers' products. Co-worker testimony on conditions and products.

Personal. An honest and complete smoking history. Concealing or minimizing it does not help; it is discoverable, and a claim built around an inaccurate history is worse than one that addresses the interaction directly.

Claims run against the manufacturers of the asbestos-containing products. Many reorganized in bankruptcy — the GAO counted 60 asbestos trusts holding roughly $37 billion in assets at its 2011 review — and trusts frequently apply distinct medical criteria to lung cancer claims. See trust claims and tort suits.

Deadlines run as they do for other asbestos diseases, generally from the date of diagnosis. See statute of limitations in asbestos cases.

If you smoked, you have probably already decided this page doesn't apply to you. That's the assumption worth checking, because the evidence doesn't support it and the law doesn't either.

We'll look at the exposure history honestly, smoking included, and tell you what we think it supports. There's no cost to that conversation, and no fee unless we win. If you'd rather start by gathering old chest imaging, that's worth doing anyway — scans taken years ago for something else sometimes carry the findings these cases turn on.

It costs nothing to find out where your family stands.